SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today Why Azenta AZTA looks attractive at current levels Bullish Momentum 20260508 Rivian Automotive RIVN Q1 2026 Earnings Deep Dive Mixed Results Amid R2 Launch Transition Cost Pressures and Autonomy Investments What share turnover IB Acquisition IBAC Flatline 20260501